Slide 1: Third Quarter Earnings
Third Quarter Earnings OCTOBER 21, 2014
Slide 2: Agenda
AGENDA IDEX’s Outlook Q3 2014 Financial Performance Q3 2014 Segment Performance • Fluid & Metering • Health & Science • Fire & Safety / Diversified Guidance Update Q&A 1
Slide 3: Replay Information
REPLAY INFORMATION Dial toll–free: 877.660.6853 International: 201.612.7415 Conference ID: #13589617 Log on to: www.idexcorp.com 2
Slide 4: Cautionary Statement Under the Private Securities Litigation Reform Act
Cautionary Statement Under the Private Securities Litigation Reform Act This presentation and discussion will include forward-looking statements. Our actual performance may differ materially from that indicated or suggested by any such statements. There are a number of factors that could cause those
Slide 5: IDEX Q3 Financial Performance
Revenue Organic: 7% increase 100 bps expansion EPS Operating Margin Free Cash Flow Organic sales growth and margin expansion delivers 13 percent EPS growth 13% increase 19% decrease IDEX Q3 Financial Performance 4 $0 $200 $400 $600 Q3 $491 $533 2013 2014 $0.00 $0.50 $1.00 Q3 $0.78 $0.88 2013 2014 15
Slide 6: Fluid & Metering
Orders Revenue Q3 Revenue Mix: Organic 4% Acquisition 1% Fx 0% Total 5% Q3 Summary: Solid sales growth provides confidence that our core end-markets are stable, and that we are well positioned going forward Water Services sales growth driven by share gain from the successful introduction of new
Slide 7: Health & Science
Health & Science Orders Revenue Operating Margin Q3 Revenue Mix: Organic 5% Acquisition 0% Fx 2% Total 7% Q3 Summary: MPT sales and profit grew significantly in Q3 MPT orders declined in Q3 due to difficult prior-year comparison and project- based business Industrial business order and sales g
Slide 8: Fire & Safety / Diversified
Orders Revenue 420 bps expansion Organic: 20% decrease Operating Margin Q3 Revenue Mix: Organic 18% Acquisition 0% Fx 1% Total 19% Q3 Summary: Orders decreased primarily due to large Dispensing order in prior year Band-It continues to grow orders and sales in nearly all end-markets, with a conti
Slide 9: Outlook: 2014 Guidance Summary
Q4 2014 EPS estimate range: $0.85 – $0.88 Operating margin: ~ 20% Tax rate: ~ 28.5% (assumes passage of US R&D tax credit) Fx impact: ~2% headwind FY 2014 EPS estimate range: $3.52 – $3.55 Organic revenue growth: ~ 5% – 6% Operating margin: > 20% Fx impact is immaterial Other modeling items • Tax ra
Slide 10: Q&A
Q&A 9